Terms: = Breast cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
77 results:
1. Comparative genomic analysis of pik3r1-mutated and wild-type breast cancers.
Cobleigh MA; Layng KV; Mauer E; Mahon B; Hockenberry AJ; Abukhdeir AM
Breast Cancer Res Treat; 2024 Apr; 204(2):407-414. PubMed ID: 38153569
[TBL] [Abstract] [Full Text] [Related]
2. Oncolytic Activity of Canine Distemper Virus in Human Ductal breast Carcinoma Cells.
Jhala D; Nathani N; Joshi M; Patel A; Joshi CG
Oncol Res Treat; 2024; 47(1-2):10-17. PubMed ID: 38008084
[TBL] [Abstract] [Full Text] [Related]
3. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer.
Kim HW; Baek M; Jung S; Jang S; Lee H; Yang SH; Kwak BS; Kim SJ
Epigenetics; 2023 Dec; 18(1):2276384. PubMed ID: 37908128
[TBL] [Abstract] [Full Text] [Related]
4. Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer.
Liang H; Yin G; Shi G; Liu Z; Liu X; Li J
Anal Biochem; 2024 Jan; 684():115360. PubMed ID: 37865269
[TBL] [Abstract] [Full Text] [Related]
5. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells.
Tafti A; Shojaei S; Zali H; Karima S; Mohammadi-Yeganeh S; Mondanizadeh M
Mol Carcinog; 2023 Dec; 62(12):1960-1973. PubMed ID: 37787375
[TBL] [Abstract] [Full Text] [Related]
6. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
7. Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
Kim JY; Park S; Cho EY; Lee JE; Jung HH; Chae BJ; Kim SW; Nam SJ; Cho SY; Park YH; Ahn JS; Lee S; Im YH
Exp Mol Med; 2023 Jul; 55(7):1451-1461. PubMed ID: 37394589
[TBL] [Abstract] [Full Text] [Related]
8. Triple-negative breast Carcinoma With Apocrine and Histiocytoid Features: A Clinicopathologic and Molecular Study of 18 Cases.
Wang Y; Hacking SM; Li Z; Graff SL; Yang D; Tan L; Liu F; Zhang T; Zhao Z; Luo S; Du P; Jia S; Cheng L
Am J Surg Pathol; 2023 Sep; 47(9):1011-1018. PubMed ID: 37310016
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer.
Li J; Gao F; Su J; Pan T
Medicine (Baltimore); 2023 May; 102(19):e33605. PubMed ID: 37171324
[TBL] [Abstract] [Full Text] [Related]
10. PIK3CA and pik3r1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy.
Tharin Z; Richard C; Derangère V; Ilie A; Arnould L; Ghiringhelli F; Boidot R; Ladoire S
Sci Rep; 2023 Mar; 13(1):4467. PubMed ID: 36934165
[TBL] [Abstract] [Full Text] [Related]
11. TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic breast Carcinoma.
Webersinke G; Burghofer J; Malli T; Rammer M; Jahn SW; Niendorf A; Tavassoli FA; Moinfar F
Arch Pathol Lab Med; 2023 Dec; 147(12):1451-1457. PubMed ID: 36897999
[TBL] [Abstract] [Full Text] [Related]
12. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
Schwartz CJ; Ruiz J; Bean GR; Sirohi D; Joseph NM; Hosfield EM; Jacobs TW; Mukhtar RA; Chen YY; Krings G
Mod Pathol; 2023 May; 36(5):100125. PubMed ID: 36870308
[TBL] [Abstract] [Full Text] [Related]
13. The Impact of pik3r1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate cancer.
Chakraborty G; Nandakumar S; Hirani R; Nguyen B; Stopsack KH; Kreitzer C; Rajanala SH; Ghale R; Mazzu YZ; Pillarsetty NVK; Lee GM; Scher HI; Morris MJ; Traina T; Razavi P; Abida W; Durack JC; Solomon SB; Vander Heiden MG; Mucci LA; Wibmer AG; Schultz N; Kantoff PW
Clin Cancer Res; 2022 Aug; 28(16):3603-3617. PubMed ID: 35670774
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract] [Full Text] [Related]
15. Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
Maeda A; Ando H; Irie K; Hashimoto N; Morishige JI; Fukushima S; Okada A; Ebi H; Matsuzaki M; Iwata H; Sawaki M
Eur J Clin Pharmacol; 2022 Aug; 78(8):1239-1247. PubMed ID: 35527301
[TBL] [Abstract] [Full Text] [Related]
16. Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.
Modlin EW; Slavotinek AM; Darling TN; Lipkowitz S; Barr FG; Munster PN; Biesecker LG; Ours CA
Am J Med Genet A; 2022 Sep; 188(9):2766-2771. PubMed ID: 35441778
[TBL] [Abstract] [Full Text] [Related]
17. Pan-cancer analysis on the role of pik3r1 and PIK3R2 in human tumors.
Liu Y; Wang D; Li Z; Li X; Jin M; Jia N; Cui X; Hu G; Tang T; Yu Q
Sci Rep; 2022 Apr; 12(1):5924. PubMed ID: 35395865
[TBL] [Abstract] [Full Text] [Related]
18. A novel mutant pik3r1
Wang K; Hu Y; Xu L; Zhao S; Song C; Sun S; Li X; Li M
Mol Biol Rep; 2022 Jul; 49(7):6155-6160. PubMed ID: 35384625
[TBL] [Abstract] [Full Text] [Related]
19. Investigation of the Anticancer Effect of
Nassan MA; Aldhahrani A; Amer HH; Elhenawy A; Swelum AA; Ali OM; Zaki YH
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164019
[TBL] [Abstract] [Full Text] [Related]
20. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
[Next]
